Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Coeur D'alene. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Coeur D'alene at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive bladder cancer that has come back after a period of improvement (recurrent). Gemcitabine is a chemotherapy drug that blocks the cells from making deoxyribonucleic acid (DNA) and may kill cancer cells. Intravesical BCG is a solution containing the live BCG bacteria that is placed in the bladder via a catheter (intravesical
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this bladder cancer clinical trial in Coeur D'alene, ID
If you're searching for bladder cancer treatment options in Coeur D'alene, ID, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Coeur D'alene research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.